Logo Logo Logo Logo Logo
  • Home
    • About
    • Team
    • Solutions
    • Technology
  • Technology
  • Lateral Flow
  • Services
  • Products
  • Latest News
  • Home
    • About
    • Team
    • Solutions
    • Technology
  • Technology
  • Lateral Flow
  • Services
  • Products
  • Latest News
Company news

EpitoPredikt and EpitoGen® Technologies have been applied in the development of an epitope-based SARS-CoV-2 serology test with 99% accuracy

December 7, 2022

EpitogenX Ltd
Polwarth Building
Foresterhill Health Campus
Aberdeen, AB25 2ZD
UK


Privacy Policy
Terms of Service
Quality Policy
Quick Links and Social Media
  • Latest News
  • Contact
  • Technology
  • LinkedIn
  • Twitter

Copyright EpitogenX Ltd © 2025. All rights reserved.